Gilead Sciences (GILD)

Cost of Revenue

$6.22B

TTM · Period ending: · USD

GILD logo

GILD Cost of Revenue

Latest reported$6.22B
GILD TTM Cost of Revenue ($0.00 → $6.22B)
High-resolution chart · PNG

GILD cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
32,228,000
30,115,000
24,588,000
25,111,000
17,938,000
13,287,000
12,640,000
7,340,000
12,940,000
8,307,000
3,400,000
3,500,000
-2,200,000
-2,000,000
-1,800,000
-1,700,000
-1,500,000
-2,800,000
-3,600,000
-4,300,000
-5,000,000
-4,400,000
-6,100,000
1,200,000
1,400,000
1,700,000
3,600,000
-3,200,000
-2,800,000
-2,400,000
-2,200,000
-2,000,000
-1,900,000
-1,500,000
-800,000
-400,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.